Association of Diet-Induced Hyperinsulinemia With Accelerated Growth of Prostate Cancer (LNCaP) Xenografts
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Prior research suggested that energy balance and fat intake influence prostate cancer progression, but the influence of dietary carbohydrate on prostate cancer progression has not been well characterized. We hypothesized that hyperinsulinemia resulting from high intake of refined carbohydrates would lead to more rapid growth of tumors in the murine LNCaP xenograft model of prostate cancer. METHODS: Athymic mice were injected subcutaneously with LNCaP human prostate cancer cells and, when tumors were palpable, were randomly assigned (n = 20 per group) to high carbohydrate-high fat or low carbohydrate-high fat diets. Body weight and tumor volume were measured weekly. After 9 weeks, serum levels of insulin and insulin-like growth factor 1 (IGF-1) were measured by enzyme immunoassay. AKT activation and the levels of the insulin receptor in tumor cells were determined by immunoblotting. The in vitro growth response of LNCaP cells to serum from mice in the two treatment groups was measured based on tetrazolium compound reduction. All statistical tests were two-sided. RESULTS: After 9 weeks on the experimental diets, mice on the high carbohydrate-high fat diet were heavier (mean body weight of mice on the high carbohydrate-high fat diet = 34 g versus 29.1 g on the low carbohydrate-high fat diet, difference = 4.9 g, 95% CI = 3.8 to 6.0 g; P = .003), experienced increased tumor growth (mean tumor volume in mice on high carbohydrate-high fat diet = 1695 versus 980 mm3 on low carbohydrate-high fat diet, difference = 715 mm3, 95% CI = 608 to 822 mm3; P<.001), and experienced a statistically significant increase in serum insulin and IGF-1 levels. Tumors from mice on the high carbohydrate-high fat diet had higher levels of activated AKT and modestly higher insulin receptor levels than tumors from mice on the low carbohydrate-high fat diet. Serum from mice on the high carbohydrate-high fat diet was more mitogenic for LNCaP cells in vitro than serum from mice fed the low carbohydrate-high fat diet. CONCLUSION: A diet high in refined carbohydrates is associated with increased tumor growth and with activation of signaling pathways distal to the insulin receptor in a murine model of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Prevalence of Overweight and Obesity in the United States
Crespo, C. J., & Ellen, S. (2003) · Obesity: Etiology Assessment Treatment and Prevention · doi:10.5040/9781718206601.ch-001 · Cited by 4,379
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Self-citationInsulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Self-citationDiabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Self-citationFasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 988
McKeown, N. M., Meigs, J. B., Liu, S., Saltzman, E., Wilson, P. W. F., & Jacques, P. F. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.538 · Cited by 786
Signalling role of adipose tissue: adipokines and inflammation in obesity
Trayhurn, P., & Wood, I. S. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331078 · Cited by 588
Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation Therapy
Braga-Basaria, M., Dobs, A. S., Muller, D. C., Carducci, M. A., John, M., Egan, J., & Basaria, S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9741 · Cited by 585
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Insulin sensitivity during combined androgen blockade for prostate cancer
Smith, M. R., Lee, H., & Nathan, D. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2507 · Cited by 493
Chan, J. M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.14.1099 · Cited by 433
Hellawell, G. O., Turner, G. D. H., Davies, D. R., Poulsom, R., BREWSTER, S. F., & Macaulay, V. M. (2002) · PubMed · Cited by 419
Role of Diet in Prostate Cancer Development and Progression
Chan, J. M., Gann, P. H., & Giovannucci, E. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1492 · Cited by 413
Biochimica et biophysica acta. Protein structure and molecular enzymology
ScienceDirect (2002) · Cited by 395
Basaria, S., Muller, D. C., Carducci, M. A., Egan, J., & Dobs, A. S. (2006) · Cancer · doi:10.1002/cncr.21642 · Cited by 394
Amling, C. L., Riffenburgh, R. H., Sun, L., Moul, J. W., Lance, R. S., Kusuda, L., Sexton, W. J., Soderdahl, D. W., Donahue, T. F., Foley, J. P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.132 · Cited by 385
Freedland, S. J., Aronson, W. J., Kane, C. J., Presti, J. C., Amling, C. L., Elashoff, D., & Terris, M. K. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.181 · Cited by 384
Rodriguez, C., Freedland, S. J., Deka, A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0754 · Cited by 354
Metabolic Syndrome in Normal-Weight Americans
St-Onge, M.-P., Janssen, I., & Heymsfield, S. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2222 · Cited by 307
Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study
Hsing, A. W., Chua, S., Gao, Y.-T., Gentzschein, E., Chang, L., Deng, J., & Stanczyk, F. Z. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.10.783 · Cited by 298
Nutrition, Insulin, Insulin-like Growth Factors and Cancer
(2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814147 · Cited by 272
Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer
Hammarsten, J., & Högstedt, B. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.003 · Cited by 214
Androgens Up-regulate the Insulin-like Growth Factor-I Receptor in Prostate Cancer Cells
Pandini, G., Mineo, R., Frasca, F., Roberts, C. T., Marcelli, M., Vigneri, R., & Belfiore, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1837 · Cited by 208
Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu, J. D., Haugk, K., Woodke, L., Nelson, P., Coleman, I., & Plymate, S. R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20929 · Cited by 188
IGF-I mediated survival pathways in normal and malignant cells
Kurmasheva, R. T., & Houghton, P. J. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.05.003 · Cited by 178
Signalling role of adipose tissue: adipokines and inflammation in obesity
Wood, I. S., & Trayhurn, P. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051078 · Cited by 167
Krueckl, S. L., Sikes, R. A., Edlund, N. M., Bell, R. H., Hurtado-Coll, A., Fazli, L., Gleave, M. E., & Cox, M. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2446 · Cited by 163
Hammarsten, J., & Högstedt, B. (2004) · Blood Pressure · doi:10.1080/08037050310025735 · Cited by 146
Strom, S. S., Wang, X., Pettaway, C. A., Logothetis, C. J., Yamamura, Y., Do, K.-A., Babaian, R. J., & Troncoso, P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1977 · Cited by 134
Wu, T., Giovannucci, E., Pischon, T., Hankinson, S. E., Ma, J., Rifai, N., & Rimm, E. B. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.1043 · Cited by 123
Are Findings from Studies of Obesity and Prostate Cancer Really in Conflict?
Freedland, S. J., Giovannucci, E. L., & Platz, E. A. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-0378-3 · Cited by 102
Venkateswaran, V., Klotz, L. H., & Fleshner, N. E. (2002) · PubMed · Cited by 91
Self-citationFreedland, S. J., Terris, M. K., Presti, J. C., Amling, C. L., Kane, C. J., Trock, B. J., Aronson, W. J., & SEARCH DATABASE STUDY GROUP (2004) · The Journal of Urology · doi:10.1097/01.ju.0000135302.58378.ae · Cited by 91
Rohrmann, S., Roberts, W. W., Walsh, P. C., & Platz, E. A. (2003) · The Prostate · doi:10.1002/pros.10211 · Cited by 89
Relationship between obesity and prostate cancer
Amling, C. L. (2005) · Current Opinion in Urology · doi:10.1097/01.mou.0000165550.94663.fb · Cited by 78
Platz, E. A., Leitzmann, M. F., Michaud, D. S., Willett, W. C., & Giovannucci, E. L. (2003) · PubMed · Cited by 75
Dombrowski, F., Mathieu, C., & Evert, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2787 · Cited by 68
Obesity and Prostate Cancer: A Growing Problem
Freedland, S. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1305 · Cited by 66
Fernández, M. L. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00325.x · Cited by 65
Friedberg, C. E., van Buren, M., Bijlsma, J. A., & Koomans, H. A. (1991) · Kidney International · doi:10.1038/ki.1991.207 · Cited by 59
Lehrer, S., Diamond, E. J., Stagger, S., Stone, N. N., & Stock, R. G. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600526 · Cited by 51
Huffman, D. M., Johnson, M. S., Watts, A., Elgavish, A., Eltoum, I. A., & Nagy, T. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1244 · Cited by 47
Hsieh, L., Carter, H. B., Landis, P., Tucker, K. L., Metter, E. J., Newschaffer, C. J., & Platz, E. A. (2003) · Urology · doi:10.1016/s0090-4295(02)02120-9 · Cited by 46
Fernández, M. L. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.jun.s30-s34 · Cited by 45
Yang, E. J., Kerver, J. M., Park, Y. K., Kayitsinga, J., Allison, D. B., & Song, W. O. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.6.1426 · Cited by 43
Metformin is an AMP Kinase-Dependent Growth Inhibitor for Breast Cancer Cells
Zakikhani, M., Dowling, R. J. O., Fantus, I. G., Sonenberg, N., & Pollak, M. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000256746.99250.dd · Cited by 42
Self-citationIs there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer?
Mavropoulos, J. C., Isaacs, W. B., Pizzo, S. V., & Freedland, S. J. (2006) · Urology · doi:10.1016/j.urology.2006.03.073 · Cited by 42
Insulin and IGF-I as determinants of low 'Western' cancer rates in the rural third world
McCarty, M. F. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh265 · Cited by 25
Prediagnostic plasma C-peptide levels and prostate cancer incidence and survival.
Ma, J., Li, H., Pollak, M., Kurth, T., Giovannucci, E. L., & Stampfer, M. J. (2006) · Cancer Epidemiology and Prevention Biomarkers · Cited by 5
Self-citation
Cited by
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
Shai, I., Schwarzfuchs, D., Henkin, Y., Shahar, D. R., Witkow, S., Greenberg, I., Golan, R., Fraser, D., Bolotin, A., Vardi, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708681 · Cited by 2,143
“Finally, although low-fat diets slow prostate cancer (PCa) growth in mice independent of weight loss [6,7], low-carbohydrate diets appear to slow experimental PCa growth as much as low-fat diets [8,9].”
BackgroundInsulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
“The influence of host hyperinsulinaemia on cancer behaviour has been the subject of recent experiments (for example see Ref”
BackgroundSelf-citationThe hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
Self-citation
Metadata
- Authors
- Venkateswaran, V., Haddad, A. Q., Fleshner, N. E., Fan, R., Sugar, L. M., Nam, R., Klotz, L. H., & Pollak, M.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-27
- Volume
- 99
- Issue
- 23
- Pages
- 1793-1800
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2160222998
- Cited by
- 182
- References
- 53
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.